enVVeno Medical (NASDAQ:NVNO) Shares Up 6.4% – What’s Next?

Shares of enVVeno Medical Corporation (NASDAQ:NVNO) rose 6.4% during trading on Thursday . The company traded as high as $3.85 and last traded at $3.82. Approximately 137,510 shares changed hands during mid-day trading, an increase of 24% from the average daily volume of 111,185 shares. The stock had previously closed at $3.59.

enVVeno Medical Trading Down 1.3 %

The company has a market cap of $66.13 million, a PE ratio of -2.92 and a beta of 1.22. The firm’s 50-day simple moving average is $3.20 and its two-hundred day simple moving average is $3.75.

Institutional Investors Weigh In On enVVeno Medical

Large investors have recently made changes to their positions in the stock. Sanctuary Advisors LLC acquired a new stake in enVVeno Medical during the 4th quarter worth about $39,000. Jane Street Group LLC acquired a new stake in shares of enVVeno Medical during the fourth quarter worth about $56,000. National Bank of Canada FI purchased a new stake in enVVeno Medical in the fourth quarter valued at approximately $60,000. Virtu Financial LLC purchased a new stake in enVVeno Medical in the fourth quarter valued at approximately $86,000. Finally, Fermata Advisors LLC increased its holdings in enVVeno Medical by 18.1% in the 4th quarter. Fermata Advisors LLC now owns 35,706 shares of the company’s stock worth $108,000 after buying an additional 5,481 shares during the period. 34.71% of the stock is owned by hedge funds and other institutional investors.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).